Evidence map›Paper›PMID 23705967›Full record

ArticleLangmuir : the ACS journal of surfaces and colloids2013

Surface modification of a biodegradable magnesium alloy with phosphorylcholine (PC) and sulfobetaine (SB) functional macromolecules for reduced thrombogenicity and acute corrosion resistance.

Sang-Ho Ye, Yong-Seok Jang, Yeo-Heung Yun, Venkat Shankarraman, Joshua R Woolley, Yi Hong, Lara J Gamble, Kazuhiko Ishihara, William R Wagner

Abstract read
In one paragraph

Article in Langmuir : the ACS journal of surfaces and colloids, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Sang-Ho YeMcGowan Institute for Regenerative Medicine,University of Pittsburgh, Pittsburgh, Pennsylvania 15219, United States.
Yong-Seok Jang
Yeo-Heung Yun
Venkat Shankarraman
Joshua R Woolley
Yi Hong
Lara J Gamble
Kazuhiko Ishihara
William R Wagner
University of Pittsburgh · USNorth Carolina Agricultural and Technical State University · USThe University of Texas at Arlington · USThe University of Tokyo · JPUniversity of Washington · US

Funding

Surface Analysis Facility for Biomedical ProblemsP41EB002027 · NIBIB · UNIVERSITY OF WASHINGTON · PI CASTNER, DAVID G · 2003 to 2019
$17.6M
Cardiovascular Bioengineering Training ProgramT32HL076124 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SANJEEV G SHROFF · 2005 to 2026
$7.0M
NHLBI NIH HHS T32 HL076124NHLBI NIH HHS T32-HL076124NIBIB NIH HHS EB-002027NIBIB NIH HHS P41 EB002027
6 · The paper itself

Abstract

Siloxane functionalized phosphorylcholine (PC) or sulfobetaine (SB) macromolecules (PCSSi or SBSSi) were synthesized to act as surface modifying agents for degradable metallic surfaces to improve acute blood compatibility and slow initial corrosion rates. The macromolecules were synthesized using a thiol-ene radical photopolymerization technique and then utilized to modify magnesium (Mg) alloy (AZ31) surfaces via an anhydrous phase deposition of the silane functional groups. X-ray photoelectron spectroscopy surface analysis results indicated successful surface modification based on increased nitrogen and phosphorus or sulfur composition on the modified surfaces relative to unmodified AZ31. In vitro acute thrombogenicity assessment after ovine blood contact with the PCSSi and SBSSi modified surfaces showed a significant decrease in platelet deposition and bulk phase platelet activation compared with the control alloy surfaces. Potentiodynamic polarization and electrochemical impedance spectroscopy data obtained from electrochemical corrosion testing demonstrated increased corrosion resistance for PCSSi- and SBSSi-modified AZ31 versus unmodified surfaces. The developed coating technique using PCSSi or SBSSi showed promise in acutely reducing both the corrosion and thrombotic processes, which would be attractive for application to blood contacting devices, such as vascular stents, made from degradable Mg alloys.

Indexed as

AlloysAnimalsBetaineBiocompatible MaterialsBlood PlateletsMagnesiumPhosphorylcholinePhotoelectron SpectroscopyPlatelet ActivationSheepSheep, DomesticSiloxanesSurface PropertiesThrombosisAlloysBetaineBiocompatible MaterialsMagnesiumPhosphorylcholineSiloxanessulfobetaine

Identifiers

PMID23705967
PMCPMC3716277
OpenAlexW1987116044

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.